secwatch.observer — SEC 8-K summary
======================================

Issuer:     IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
CIK:        0001425205
Form:       8-K
Filed at:   2024-02-22T23:59:59+00:00
Accession:  0001104659-24-026578
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iovance closes $197.1M public offering of 23M shares at $9.15/share
-------------------------------------------------------------------

- Closed sale of 23,014,000 shares at $9.15 per share in underwritten offering.
- Net proceeds expected to be approximately $197.1M after discounts and expenses.
- Offering previously disclosed; closing occurred on February 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425205/000110465924026578/0001104659-24-026578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425205/000110465924026578/tm246821d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-026578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer